129 related articles for article (PubMed ID: 36199998)
1. Radiation-induced undifferentiated spindle cell sarcoma following high-dose-rate interstitial brachytherapy for tongue squamous cell carcinoma.
Uchimoto Y; Shimamoto H; Takeshita A; Oya K; Kishino M; Fukuda Y; Toyosawa S; Oda M; Ogawa K; Kreiborg S; Mallya SM; Murakami S
J Contemp Brachytherapy; 2022 Jun; 14(3):268-272. PubMed ID: 36199998
[TBL] [Abstract][Full Text] [Related]
2. Results of low- and high-dose-rate interstitial brachytherapy for T3 mobile tongue cancer.
Kakimoto N; Inoue T; Inoue T; Murakami S; Furukawa S; Yoshida K; Yoshioka Y; Yamazaki H; Tanaka E; Shimizutani K
Radiother Oncol; 2003 Aug; 68(2):123-8. PubMed ID: 12972306
[TBL] [Abstract][Full Text] [Related]
3. Image-guided interstitial brachytherapy boost for keratinizing squamous cell carcinoma of inferior wall of the nasopharynx.
Murakami N; Yoshimoto S; Uematsu M; Kashihara T; Takahashi K; Inaba K; Okuma K; Igaki H; Nakayama Y; Masui K; Yoshida K; Itami J
BJR Case Rep; 2020 Dec; 6(4):20200005. PubMed ID: 33299579
[TBL] [Abstract][Full Text] [Related]
4. Per-oral interstitial brachytherapy catheter insertion for boost in case of recurrent tonsillar carcinoma: dosimetry and clinical outcome.
Murakami N; Yoshimoto S; Nakamura S; Uematsu M; Kashihara T; Takahashi K; Inaba K; Okuma K; Igaki H; Nakayama Y; Itami J
BJR Case Rep; 2020 Mar; 6(1):20190059. PubMed ID: 32201608
[TBL] [Abstract][Full Text] [Related]
5. High-Dose-Rate Interstitial Brachytherapy for Deeply Situated Gynecologic Tumors Guided by Combination of Transrectal and Transabdominal Ultrasonography: A Technical Note.
Shimizu Y; Murakami N; Chiba T; Kaneda T; Okamoto H; Nakamura S; Takahashi A; Kashihara T; Takahashi K; Inaba K; Okuma K; Nakayama Y; Itami J; Igaki H
Front Oncol; 2021; 11():808721. PubMed ID: 35155202
[TBL] [Abstract][Full Text] [Related]
6. A case report of a patient with bulky uterine cervical neoplasm who achieved complete response with "intentional internal high-dose policy" high-dose-rate interstitial brachytherapy.
Kashihara T; Kobayashi K; Iijima K; Murakami N; Yoshida K; Okuma K; Nakamura S; Takahashi K; Inaba K; Igaki H; Nakayama Y; Kato T; Uno T; Itami J
Medicine (Baltimore); 2020 Jul; 99(27):e20860. PubMed ID: 32629674
[TBL] [Abstract][Full Text] [Related]
7. Brachytherapy for Buccal Cancer: From Conventional Low Dose Rate (LDR) or Mold Technique to High Dose Rate Interstitial Brachytherapy (HDR-ISBT).
Kotsuma T; Yamazaki H; Masui K; Yoshida K; Shimizutani K; Akiyama H; Murakami S; Isohashi F; Yoshioka Y; Ogawa K; Tanaka E
Anticancer Res; 2017 Dec; 37(12):6887-6892. PubMed ID: 29187469
[TBL] [Abstract][Full Text] [Related]
8. High-dose-rate interstitial brachytherapy as a suitable option for metastatic extraskeletal myxoid chondrosarcoma - a case report.
Takagawa Y; Murakami N; Igaki H; Okamoto H; Itami J
J Contemp Brachytherapy; 2022 Apr; 14(2):198-204. PubMed ID: 35494187
[TBL] [Abstract][Full Text] [Related]
9. Technical report: a high-dose-rate interstitial brachytherapy boost for residual sinonasal undifferentiated carcinoma.
Miyata Y; Murakami N; Honma Y; Mori T; Yoshimoto S; Kashihara T; Takemori M; Nakayama Y; Itami J; Ogo E; Igaki H
J Radiat Res; 2022 Dec; 63(6):879-883. PubMed ID: 36149017
[TBL] [Abstract][Full Text] [Related]
10. Dose reduction trial from 60 Gy in 10 fractions to 54 Gy in 9 fractions schedule in high-dose-rate interstitial brachytherapy for early oral tongue cancer.
Akiyama H; Yoshida K; Shimizutani K; Yamazaki H; Koizumi M; Yoshioka Y; Kakimoto N; Murakami S; Furukawa S; Ogawa K
J Radiat Res; 2012 Sep; 53(5):722-6. PubMed ID: 22843365
[TBL] [Abstract][Full Text] [Related]
11. Phase III trial of high and low dose rate interstitial radiotherapy for early oral tongue cancer.
Inoue T; Inoue T; Teshima T; Murayama S; Shimizutani K; Fuchihata H; Furukawa S
Int J Radiat Oncol Biol Phys; 1996 Dec; 36(5):1201-4. PubMed ID: 8985043
[TBL] [Abstract][Full Text] [Related]
12. Outpatient-based high-dose-rate interstitial brachytherapy for gynecologic malignancies.
Dyk PT; Richardson S; Badiyan SN; Schwarz JK; Esthappan J; Garcia-Ramirez JL; Grigsby PW
Brachytherapy; 2015; 14(2):231-7. PubMed ID: 25556865
[TBL] [Abstract][Full Text] [Related]
13. The impact of tumor size and histology on local control when utilizing high-dose-rate interstitial brachytherapy for gynecologic malignancies.
Schiff JP; Mahmood M; Huang Y; Powell MA; Mutch D; Dyk PT; Lin AJ; Schwarz JK; Markovina ST; Grigsby PW
Gynecol Oncol; 2022 Jun; 165(3):486-492. PubMed ID: 35370010
[TBL] [Abstract][Full Text] [Related]
14. Fibre-optic endoscope-guided three-dimensional high-dose-rate interstitial brachytherapy for residual nasopharyngeal carcinoma after conventional external beam radiotherapy.
Zhang X; Wu N; Zhao Z; Han D; He M; Yang W; Cheng G
J Contemp Brachytherapy; 2019 Jun; 11(3):243-249. PubMed ID: 31435431
[TBL] [Abstract][Full Text] [Related]
15. Primary peritoneal clear cell carcinoma treated with IMRT and interstitial HDR brachytherapy: a case report.
Johnson SB; Prisciandaro JI; Zhou J; Hadley SW; Reynolds RK; Jolly S
J Appl Clin Med Phys; 2014 Jan; 15(1):4520. PubMed ID: 24423851
[TBL] [Abstract][Full Text] [Related]
16. Patterns of brachytherapy practice for patients with carcinoma of the cervix (1996-1999): a patterns of care study.
Erickson B; Eifel P; Moughan J; Rownd J; Iarocci T; Owen J
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1083-92. PubMed ID: 16099599
[TBL] [Abstract][Full Text] [Related]
17. Management of Bartholin's gland carcinoma using high-dose-rate interstitial brachytherapy boost.
Thibault I; Lavallée MC; Aubin S; Jain S; Laflamme N; Vigneault É
Brachytherapy; 2013; 12(5):500-7. PubMed ID: 23406985
[TBL] [Abstract][Full Text] [Related]
18. Unresectable bulky chest wall recurrent breast cancer controlled with CT-guided interstitial high-dose-rate brachytherapy and external beam radiotherapy with adjuvant hormonal therapy - case report.
Kunogi H; Hsu IC; Sasai K
J Contemp Brachytherapy; 2021 Aug; 13(4):451-457. PubMed ID: 34484361
[TBL] [Abstract][Full Text] [Related]
19. High-dose-rate interstitial brachytherapy for mobile tongue cancer: influence of the non-irradiated period.
Kakimoto N; Inoue T; Inoue T; Murakami S; Furukawa S; Yoshida K; Yoshioka Y; Yamazaki H; Tanaka E; Shimizutani K
Anticancer Res; 2006; 26(5B):3933-7. PubMed ID: 17094424
[TBL] [Abstract][Full Text] [Related]
20. Challenge and Outcome for the Prostate Squamous Cell Carcinoma Which Developed 8 Years after Low-Dose-Rate Brachytherapy Approached by a Combined Multimodal Treatment with High-Dose-Rate Interstitial Brachytherapy, External Beam Radiation Therapy, and Chemotherapy.
Matsugasumi T; Masui K; Yamada K; Watanabe S; Okihara K; Kozawa N; Yamada Y; Yamazaki H; Yamada K; Ukimura O
Case Rep Oncol; 2021; 14(2):854-860. PubMed ID: 34248551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
